On October 19, CDC Director Rochelle P. Walensky, MD, MPH, released a media statement allowing Novavax monovalent COVID-19 boosters for adults targeting the original COVID-19 strain. Her decision follows the emergency use authorization granted by the Food and Drug Administration.
Novavax monovalent COVID-19 boosters are available for adults if they have completed primary series vaccination but have not previously received a COVID-19 booster—and if they cannot or will not receive an updated mRNA booster.
CDC recommends that everyone ages 6 months and older stay up to date with COVID-19 vaccination. Persons 5 years and older are up to date if they have completed a primary series and received the most recent booster dose recommended by CDC. Vaccines are highly effective at protecting people from serious illness and remains the best way to protect from severe COVID-19 hospitalization and death. Read the full media statement at CDC Allows Novavax Monovalent COVID-19 Boosters for Adults Ages 18 and Older.